
Sustainable Implementation of Quality Risk Management
The global pharmaceutical industry continues to face unexpected challenges in responding to the world’s pandemic. The impact on normal operations has been felt in companies of all sizes, with varying types of manufacturing capabilities, no more intensely than in the Asia Pacific region. The 2021 ISPE Asia Pacific Pharmaceutical Manufacturing Conference will address this impact and the most critical issues, with special emphasis on practical application using a series of case studies implementing Quality Risk Management principals.
As companies in this region adapt to new interpretations of existing regulations, contend with remote inspections, and manage an increasing number of CMOs, effective quality risk assessment and risk mitigation have become exponentially more significant. Full transparency with regulatory agencies and comprehensive responses to regulatory actions is imperative to ensure product quality, safety, and efficacy.
ISPE Members can save up to $145 and get exclusive on demand access* to the 45-minute session "Data Integrity in Quality Systems & Automated Technology" featuring:
Just use code APAC21 at checkout to secure your video access. Hurry, this offer expires after 16 April 2021.
*On demand access to the 45-minute session "Data Integrity in Quality Systems & Automated Technology" will be available 21 April 2021 through 21 May 2021. You will receive access details via email on 21 April 2021.
At the conclusion of the conference, attendees will be able to: